ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival

Human ASPM participates in spindle organisation, spindle orientation and cytokinesis

(2010) Julie Higgins et al.   BMC CELL BIOLOGY

Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells

(2010) N Ingram et al.   CANCER GENE THERAPY

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY

Integrative Genome Comparison of Primary and Metastatic Melanomas

(2010) Omar Kabbarah et al.   PLoS One

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers

(2009) Y-K Lee et al.   BRITISH JOURNAL OF CANCER

Microcephalin Regulates BRCA2 and Rad51-Associated DNA Double-Strand Break Repair

(2009) Xianglin Wu et al.   CANCER RESEARCH

Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1

(2009) Alexandra Tibelius et al.   JOURNAL OF CELL BIOLOGY

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

(2009) Michael A. Bookman et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles

(2009) Kenneth E. Scarberry et al.   Nanomedicine-Nanotechnology Biology and Medicine

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

(2008) S.-Y. Lin et al.   CLINICAL CANCER RESEARCH